- Home
- RYTM vs VNO Comparison
RYTM vs VNO Comparison
Compare RYTM & VNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- VNO
- Stock Information
- Founded
- RYTM 2008
- VNO 1946
- Country
- RYTM United States
- VNO United States
- Employees
- RYTM N/A
- VNO N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- VNO Real Estate Investment Trusts
- Sector
- RYTM Health Care
- VNO Real Estate
- Exchange
- RYTM Nasdaq
- VNO Nasdaq
- Market Cap
- RYTM 5.9B
- VNO 7.0B
- IPO Year
- RYTM 2017
- VNO N/A
- Fundamental
- Price
- RYTM $88.64
- VNO $40.09
- Analyst Decision
- RYTM Strong Buy
- VNO Hold
- Analyst Count
- RYTM 13
- VNO 11
- Target Price
- RYTM $89.77
- VNO $38.09
- AVG Volume (30 Days)
- RYTM 1.0M
- VNO 2.0M
- Earning Date
- RYTM 08-05-2025
- VNO 08-04-2025
- Dividend Yield
- RYTM N/A
- VNO 1.91%
- EPS Growth
- RYTM N/A
- VNO 248.25
- EPS
- RYTM N/A
- VNO 0.52
- Revenue
- RYTM $136,863,000.00
- VNO $1,929,890,000.00
- Revenue This Year
- RYTM $37.47
- VNO N/A
- Revenue Next Year
- RYTM $71.16
- VNO $4.97
- P/E Ratio
- RYTM N/A
- VNO $73.80
- Revenue Growth
- RYTM 48.88
- VNO 2.98
- 52 Week Low
- RYTM $40.61
- VNO $26.19
- 52 Week High
- RYTM $94.80
- VNO $46.63
- Technical
- Relative Strength Index (RSI)
- RYTM 71.18
- VNO 60.36
- Support Level
- RYTM $87.86
- VNO $38.30
- Resistance Level
- RYTM $92.14
- VNO $39.68
- Average True Range (ATR)
- RYTM 3.57
- VNO 0.91
- MACD
- RYTM 1.01
- VNO 0.19
- Stochastic Oscillator
- RYTM 77.38
- VNO 92.48
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About VNO Vornado Realty Trust
Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.